These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6766335)

  • 21. Factor VIII/von Willebrand factor binding to von Willebrand's disease platelets.
    Gralnick HR; Williams SB; Shafer BC; Corash L
    Blood; 1982 Aug; 60(2):328-32. PubMed ID: 6807372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.
    Read MS; Shermer RW; Brinkhous KM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4514-8. PubMed ID: 309134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vancomycin on ristocetin and bovine PAF-induced agglutination of human platelets.
    Baugh RF; Jacoby C; Brown JE; Hougie C
    Thromb Res; 1978 Mar; 12(3):511-21. PubMed ID: 306689
    [No Abstract]   [Full Text] [Related]  

  • 25. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
    Senogles SE; Nelsestuen GL
    J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective binding of the factor VIII/von Willebrand factor protein to human platelets.
    Morisato DK; Gralnick HR
    Blood; 1980 Jan; 55(1):9-15. PubMed ID: 6965350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
    Andersen JC; Switzer ME; McKee PA
    Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin as well as ristocetin facilitates von Willebrand factor binding to platelets.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jul 1-15; 19(1-2):287-92. PubMed ID: 6969463
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of platelet agglutination induced by the antibiotics of the vancomycin group: ristocetin, ristomycin, actinoidin and vancomycin.
    Boda Z; Solum NO; Sztaricskai F; Rak K
    Thromb Haemost; 1979 Dec; 42(4):1164-80. PubMed ID: 232315
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
    Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
    J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the effect of modification of the surface of human platelets on the receptors for aggregated immunoglobulins and for ristocentin-von Willebrand factor.
    Pfueller SL; Jenkins CS; Lüscher EF
    Biochim Biophys Acta; 1977 Mar; 465(3):614-26. PubMed ID: 319830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination].
    Rák K; Boda Z; Sztaricskai F
    Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alpha 1-acid glycoprotein on ristocetin, thrombin and Polybrene induced platelet aggregation.
    Coller BS
    Thromb Res; 1980 May 1-15; 18(3-4):579-84. PubMed ID: 6774438
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of ristocetin and von Willebrand factor.
    Jenkins CS; Meyer D; Larrieu MJ
    Thromb Haemost; 1976 Jun; 35(3):752-3. PubMed ID: 1086517
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphological studies of platelet aggregates induced by human von Willebrand factor in platelet-type von Willebrand's disease.
    Takahashi H; Hattori A; Nagayama R; Hanano M; Fuse I; Takizawa S; Takeshige T; Shibata A
    Thromb Res; 1985 May; 38(4):433-8. PubMed ID: 3874446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.